Recent

% | $
Quotes you view appear here for quick access.

Cempra Inc Message Board

SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Yeah, you certainly sound like the husband of a large pharma Director...congrats on marrying up...like up thru the stratosphere. You would like Pro...his Uncle is an astronaut...you two could entertain each other for hours.

  • Dummy.. you would cream if you had just a percentage of our shares....

  • It is certainly a buy here. I do get bronchitis, and not the flu, so this is actually a help to me.

    Just because a company may hit it out of the park scientifically, does not mean they are qualified marketers. We have already made a huge profit from the first run from 18 to the 30's and our cost is low.

    My point is if they partnered with a company that had several drugs salesman will have more success. This is still not a first line script. There is nothing wrong with raising money but every time they do they dilute.

    Doesn't really matter to me if it takes another 24 months, but it takes a full 24-36 months for new drug market penetration and the start up costs are high launching. All I stated was that management was not shareholder friendly and the market agrees. CEMP is a very big position of ours

  • Yes it does. They have a GERD trial scheduled see the pipeline on the website. Trials and approvals for these will come in coming years. They also report efficacy against malaria and anthrax.

  • Director of office supplies? Director of janitorial services?

  • There is so much wrong with this post that I am having trouble articulating my true disgust. This argument is everything that is wrong with biotech. "Im mad because the CEO isn't corrupt and peddling snake oil". This is why Skhreli's antics were able to crash the entire sector. This is why presidential candidates and the chair of the federal reserve single out biotech.

  • Srpt fails a trial miserably. FDA advisory board rejects the drug. Srpt stock price goes up after all the bad news. Cemp has a good trial, stock tanks after news. Cemp files NDA, stock goes down again. No matter what Cemp CEO has to say, stock goes down. So what's the difference? Srpt had a CEO who knows what he's doing. He gets his hedge fund buddies to lobby on his behalf. He rallies the troops and gets parents and children who have DMD to show up at FDA meetings and works on J. Woodcocks emotions. He gets corrupt politician Rubio to make a speech on why his drugs should get approved on the senate floor. Cemp CEO? Clueless in ever sense of the word. No experience, doesn't know how to use outside resources. Foolishly thinks she can go it alone without outside intervention. Has a BOD that are just as useless as her. If ever there were two polar opposites in terms of biotech companies, look no further than Srpt and Cemp. In a million years Srpt drug should never be approved, yet, they have the FDA eating out of their hands. Cemp on the other hand is like a bird flying overhead when you're in your best Sunday suit and the bird S*%ts all over you. Get the picture?

  • Reply to

    MIA

    by stilllondgo Apr 19, 2016 2:27 PM

    Click on stillondgo's name and read his posts. He goes to a bunch of boards and says i told you so, you're all idiots, i'm the master over and over again. The most pathetic thing i've ever seen. Wow.

  • NEVER overstate...lol massive pump on management. No problem right that EU will be ok with Soli not meeting NI, because they couldn't get it through customs in Russia for one. But bottom line it FAILED NI. Prabha says no problem with ALT-3 levels with FDA you sure? Prabha says GONO trial wasn't sufficient enough for women and children so we need a new trial so we can add that data into the completed PHIII trial then we can publish. Prabha says we are open to partners in EU, open to the right partner or possibly considering going it alone, in a CC then the shelf hits, come to find Prabha sells shares then before the shelf. All the CC's never factor in that the generics for competition may be a problem because of pricing, just assume Soli's going to take over fast as the number #1 prescribe antibiotic at the cost Prabha sets. Maybe what Prabha is saying is all true in mind.. GOOD LUCK.

  • Reply to

    MIA

    by stilllondgo Apr 19, 2016 2:27 PM

    I put all of these trolls in ignore.....you guys might try the same.

  • I was referring to cempra's go to market strategy. They haven't done anything different from what they've said they would do since PH3 trials came in.

    And I don't expect to hear back from you, but what specifically has Prabha overstated that has you so worked up? Specifically means quote her, her actual words. I know you deal in platitudes, but this is a challenge. Use real evidence when you post.

  • It is certainly a buy here. I do get bronchitis, and not the flu, so this is actually a help to me.

    Just because a company may hit it out of the park scientifically, does not mean they are qualified marketers. We have already made a huge profit from the first run from 18 to the 30's and our cost is low.

    My point is if they partnered with a company that had several drugs salesman will have more success. This is still not a first line script. There is nothing wrong with raising money but every time they do they dilute.

    Doesn't really matter to me if it takes another 24 months, but it takes a full 24-36 months for new drug market penetration and the start up costs are high launching. All I stated was that management was not shareholder friendly and the market agrees. CEMP is a very big position of ours

  • "Prabha and her team have NEVER tried to overstate and over-market what they are doing." You can't be serious, some of the things that pumper say makes me LMAO....the way Praba talks and pumps Soli wants to con every one into believing it's the greatest ABX discovered and can cure all other sorts of ailments, lol.

  • Reply to

    MIA

    by stilllondgo Apr 19, 2016 2:27 PM

    We're human beings here. We're not "enemies." I bet most of us work hard and try and live right and behave decently to others. Please, one of you, explain your meanness.

  • Reply to

    MIA

    by stilllondgo Apr 19, 2016 2:27 PM

    I don't get why you guys (or guy) are just so nasty. Is it really necessary? Seriously, I don't get it. Don't you think the world is a bad enough place without you adding to its nastiness?

  • Reply to

    MIA

    by stilllondgo Apr 19, 2016 2:27 PM

    where is kitty? always big mouth - now what ???

    I guess they took her trailer away.

  • This post is oh so very ignorant and short sighted. Cempra does not need to apologize that their end game is different from the one you prefer. Raising money and hiring a sales force are the exact actions a company should do when they are preparing to sell a product for a long time. They believe they can sell this drug effectively. Prabha and her team have NEVER tried to overstate and over-market what they are doing. They have stated their strategy and intentions over and over. Should they have hired a blimp to fly over NC so that johnces1313 can get a bump in the stock's price? They are being completely transparent and DON'T OWE YOU ANYTHING MORE. Your last sentence says it all. You are the one who needs to catch up to the reality of what the company has been telling you ad nauseam. Don't blame the very small company for not spending their marketing allocation the way you prescribe it. They are putting boots on the ground. And this IS a happy time, despite the price of the stock. When it's all said and done, this time in biotech will go down in history as one of the most mainpulated eras of any sector - ever.

  • They could care less about shareholders. I bought in loving the story watched it go up and down a couple times, no big deal because this was a life saving new class antibiotic. Even as a second line drug this was appealing'

    It is not Cemp's fault the whole bio sector is down. But raising money, diluting and then hiring a 200 sales force hurts any acquisition premium. Senior management does not care because they are protecting thier salaries.

    My wife is director at very big pharma, NDA submissions are happy times and the stock should be double. This is going to be much longer term that I thought

  • Is coming the first week of November, watch. IMHO

  • TPB is right about Goldy. They often trade against their recs and often make bad calls. I don't trust them one bit.

    I give much more weight to the fact that Fidelity, Blackrock and Levin all bought more than 40 million worth of stock recently. I like to think I do very good DD, but those guys have the best connections in the world, and they truly define "smart money"

Must Watch
CEMP
15.84-0.26(-1.61%)May 5 4:00 PMEDT